2009
DOI: 10.1016/j.cbpa.2009.05.127
|View full text |Cite
|
Sign up to set email alerts
|

Recent advances in carbohydrate-based vaccines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
57
0

Year Published

2009
2009
2021
2021

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 98 publications
(57 citation statements)
references
References 56 publications
0
57
0
Order By: Relevance
“…S1). No mass modification was found on the Endo H-treated chymotryptic peptides containing Asn 8 and Asn 29 , demonstrating the absence of glycosylation of these putative sites in the wild-type XynA. In these experiments, the sequence coverage was 100%, and the N-terminal peptide analysis revealed that the signal sequence peptidase present in P. pastoris cleaved the protein three residues upstream from the expected Kex2 signal peptide cleavage site (31).…”
Section: Ms Analysis Of Wild-type Xylanse A-thementioning
confidence: 79%
See 1 more Smart Citation
“…S1). No mass modification was found on the Endo H-treated chymotryptic peptides containing Asn 8 and Asn 29 , demonstrating the absence of glycosylation of these putative sites in the wild-type XynA. In these experiments, the sequence coverage was 100%, and the N-terminal peptide analysis revealed that the signal sequence peptidase present in P. pastoris cleaved the protein three residues upstream from the expected Kex2 signal peptide cleavage site (31).…”
Section: Ms Analysis Of Wild-type Xylanse A-thementioning
confidence: 79%
“…The biosynthesis, molecular composition, and functions of glycoproteins are well documented, and glycans can act as recognition markers (5-7); mediators of biomolecular interactions (8,9); immune response modulators (10,11); regulators of protein turnover and protein folding (12,13); and markers for protein secretion (14), intracellular trafficking, and cell communication (13,15). Due to their hydrophilicity and bulk, glycan modification can increase glycoprotein solubility, improve resistance against proteolysis, and reduce non-specific protein interactions (16).…”
mentioning
confidence: 99%
“…Thus, medicinal chemistry techniques can potentially be used to derivatize and modify synthetic carbohydrates to make vaccines that are more immunogenic than those based on natural carbohydrates. For selected, general, and recent reviews on these aspects of carbohydrate chemistry, see (a) general references [2][3][4][5]; (b) synthetic aspects [6][7][8][9]; (c) carbohydrates in biological and medicinal chemistry [10][11][12][13][14]; (d) glycobiology [15]; (e) signaling, cell-cell communication, and molecular and cellular targeting [16][17][18][19][20][21]; (f) therapeutic potential of glycoconjugates [22,23]; (g) carbohydrate-based vaccines [24][25][26][27][28].…”
Section: Introductionmentioning
confidence: 99%
“…In fact, oligosaccharides and various glycoconjugates have been shown to modulate different molecular recognition processes, including viral and bacterial pathogens recognition [1][2][3][4][5], tumor-associated cell adhesion and metastasis events [6][7][8], immune response [9], fertilization [10], and neuronal development [11]. This significant role, together with advances in the glycomics field and the recent developments of new synthetic methodologies, for example, the glycorandomization of biologically active natural products [12,13], makes glycoconjugates extremely attractive therapeutic targets nowadays [14][15][16][17].…”
Section: Introductionmentioning
confidence: 99%